Journal of Korean Traditional Oncology (대한암한의학회지)

Korean Association of Traditional Oncology (대한암한의학회)
권호 표지

A Case of Advanced Gastric Cancer Patient Treated with Sojeukjungwon-san and Allergen Removed Rhus Verniciflua Stokes(aRVS)

소적정원산(消積正元散) 및 옻나무 추출물 투여로 체중증가 및 일반활동도의 개선을 보인 진행성 위암환자 1례

  • An, Ji-Hye (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center) ;
  • Jerng, Ui-Min (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center) ;
  • Jeong, Jong-Soo (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center) ;
  • Park, Jae-Woo (Department of Internal Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Yoon, Seong-Woo (M.U Integrative Cancer Center, Kyunghee East-West Neo Medical Center)
  • 안지혜 (경희대학교 동서신의학병원 한방암센터) ;
  • 정의민 (경희대학교 동서신의학병원 한방암센터) ;
  • 정종수 (경희대학교 동서신의학병원 한방암센터) ;
  • 박재우 (경희대학교 한의과대학 내과학교실) ;
  • 윤성우 (경희대학교 동서신의학병원 한방암센터)
  • Published : 2009.12.28
Download PDF
⟨ Previous Next ⟩

Abstract

Advanced gastric cancer is the most common type of all cancers in Korea, which account for approximately 18.1% of all incident cancers, and mortality from advanced gastric cancer is estimated at nearly 15.6% of death that caused by all cancer. In the conventional medicine, treatments of advanced gastric cancer include chemotherapy such like FOLFOX. In this case report, we introduce a case of advanced gastric cancer with greater omentum, thyroid, supraclavicular lymph node metastasis who had received chemotherapy. Chemotherapy was stopped because of weight loss and neurologic symptom such like cognitive disorder. The patient visited $M{\cdot\mu}$ Integrative cancer center in 2008, and was treated by Sojeukjungwon-san and allergen removed Rhus verniciflua stokes(aRVS). There was no evidence of brain metastasis. The patient showed improvement of cognitive disorder and gained weight. Further case study will be needed in order to determine the effects of Sojeukjungwon-san and allergen removed Rhus verniciflua stokes(aRVS) for the quality of life of advanced gastric cancer patients after chemotherapy.

Keywords